CD133 affects the invasive ability of HCT116 cells by regulating TIMP-2

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 565-576

  Zhang, Min ^a   Liu, Yanyan ^a   Feng, Hailiang ^a   Bian, Xiaocui ^a   Zhao, Wenjing ^a   Yang, Zhenli ^a   Gu, Bei ^a   Li, Zhanwen ^a   Liu, Yuqin ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL ASSAY; CELL INVASION; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIGENS, CD; CELL PROLIFERATION; CELL SEPARATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HCT116 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PEPTIDES; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84872745229     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.10.015     Document Type: Article

References (49)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011 CA: a Cancer Journal for Clinicians 61 2011 212 236
2. H. Nelson, N. Petrelli, A. Carlin, J. Couture, J. Fleshman, J. Guillem, B. Miedema, D. Ota, and D. Sargent Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst 93 2001 583 596
3. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer ed 6 staging J Natl Cancer Inst 96 2004 1420 1425
4. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
5. R. Pardal, M.F. Clarke, and S.J. Morrison Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3 2003 895 902
6. S. Miraglia, W. Godfrey, A.H. Yin, K. Atkins, R. Warnke, J.T. Holden, R.A. Bray, E.K. Waller, and D.W. Buck A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning Blood 90 1997 5013 5021
7. A.H. Yin, S. Miraglia, E.D. Zanjani, G. Almeida-Porada, M. Ogawa, A.G. Leary, J. Olweus, J. Kearney, and D.W. Buck AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002 5012
8. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
9. S. Ma, K.W. Chan, L. Hu, T.K.W. Lee, J.Y.H. Wo, I.O.L. Ng, B.J. Zheng, and X.Y. Guan Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
10. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
11. L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, and R. De Maria Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
12. K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori Biological and genetic characteristics of tumor-initiating cells in colon cancer Ann Surg Oncol 15 2008 638 648
13. S.V. Shmelkov, J.M. Butler, A.T. Hooper, A. Hormigo, J. Kushner, T. Milde, R.S. Clair, M. Baljevic, I. White, and D.K. Jin CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors J Clin Invest 118 2008 2111
14. C.W. Ong, L.G. Kim, H.H. Kong, L.Y. Low, B. Iacopetta, R. Soong, and M. Salto-Tellez CD133 expression predicts for non-response to chemotherapy in colorectal cancer Mod Pathol 23 2010 450 457
15. C.Y. Li, B.X. Li, Y. Liang, R.Q. Peng, Y. Ding, D.Z. Xu, X. Zhang, Z.Z. Pan, D.S. Wan, and Y.X. Zeng Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB J Transl Med 7 2009 56
16. D. Horst, S.K. Scheel, S. Liebmann, J. Neumann, S. Maatz, T. Kirchner, and A. Jung The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer J Pathol 219 2009 427 434
17. Q. Wang, Z.G. Chen, C.Z. Du, H.W. Wang, L. Yan, and J. Gu Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer Histopathology 55 2009 284 293
18. H.Q. Xi, and P. Zhao Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma J Clin Pathol 64 2011 498 503
19. H. Yasuda, K. Tanaka, S. Saigusa, Y. Toiyama, Y. Koike, Y. Okugawa, T. Yokoe, A. Kawamoto, Y. Inoue, and C. Miki Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer Oncol Rep 22 2009 709 717
20. A. Kabashima, Y. Maehara, Y. Kakeji, H. Baba, T. Koga, and K. Sugimachi Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis Clinical Cancer Res 6 2000 3581 3584
21. K.V. Lu, K.A. Jong, A.K. Rajasekaran, T.F. Cloughesy, and P.S. Mischel Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line Lab Invest 84 2004 8 20
22. K.S. Park, S.J. Kim, K.H. Kim, and J.C. Kim Clinical characteristics of TIMP2. MMP2, and MMP9 gene polymorphisms in colorectal cancer J Gastroenterol Hepatol 26 2011 391 397
23. B.H. Li, P. Zhao, S.Z. Liu, Y.M. Yu, M. Han, and J.K. Wen Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis World J Gastroenterol 11 2005 3046
24. J.E. Shin, S. Jung, S.E. Kim, Y.H. Joo, K.N. Shim, T.H. Kim, K. Yoo, and I.H. Moon Expression of MMP-2. HIF-1alpha and VEGF in colon adenoma and colon cancer Korean J Gastroenterol 50 2007 9 18
25. N.E. Sounni, D.V. Rozanov, A.G. Remacle, V.S. Golubkov, A. Noel, and A.Y. Strongin Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells Int J Cancer 126 2010 1067 1078
26. K. Kohga, T. Tatsumi, T. Takehara, H. Tsunematsu, S. Shimizu, M. Yamamoto, A. Sasakawa, T. Miyagi, and N. Hayashi Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma J Hepatol 52 2010 872 879
27. H.L. Feng, Y.Q. Liu, L.J. Yang, X.C. Bian, Z.L. Yang, B. Gu, H. Zhang, C.J. Wang, X.L. Su, and X.M. Zhao Expression of CD133 correlates with differentiation of human colon cancer cells Cancer Biol Ther 9 2010 216
28. L. Dong, N. Qi, R.M. Ge, C.L. Cao, F. Lan, and L. Shen Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells Neurosci Lett 484 2010 210 214
29. M. Ausiliatrice Puglisi, M. Barba, M. Corbi, M.F. Errico, E. Giorda, N. Saulnier, A. Boninsegna, A.C. Piscaglia, R. Carsetti, and A. Cittadini Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells J Pathol 225 2011 305 314
30. T.M.A. Elsaba, L. Martinez-Pomares, A.R. Robins, S. Crook, R. Seth, D. Jackson, A. McCart, A.R. Silver, I.P.M. Tomlinson, and M. Ilyas The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer PLoS One 5 2010 e10714
31. C. Dittfeld, A. Dietrich, S. Peickert, S. Hering, M. Baumann, M. Grade, T. Ried, and L.A. Kunz-Schughart CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116 Radiother Oncol 92 2009 353 361
32. K. Chen, F. Pan, H. Jiang, J. Chen, L. Pei, F. Xie, and H. Liang Highly enriched CD133+ CD44+ stem-like cells with CD133+ CD44 high metastatic subset in HCT116 colon cancer cells Clin Exp Metastasis 2011 1 13
33. L. Cui, K. Ohuchida, K. Mizumoto, T. Moriyama, M. Onimaru, K. Nakata, T. Nabae, T. Ueki, N. Sato, and Y. Tominaga Prospectively isolated cancer-associated CD10+ fibroblasts have stronger interactions with CD133+ colon cancer cells than with CD133-cancer cells PLoS One 5 2010 e12121
34. A. Sgambato, M. Puglisi, F. Errico, F. Rafanelli, A. Boninsegna, A. Rettino, G. Genovese, C. Coco, A. Gasbarrini, and A. Cittadini Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection J Cell Physiol 224 2010 234 241
35. B. Annabi, J. Doumit, K. Plouffe, C. Laflamme, S. Lord-Dufour, and R. Béliveau Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133 (+) DAOY medulloblastoma cells Mol Carcinog 49 2010 710 717
36. D. O'Dwyer, L.D. Ralton, A. O'Shea, and G.I. Murray The proteomics of colorectal cancer: identification of a protein signature associated with prognosis PloS One 6 2011 e27718
37. S. Saigusa, K. Tanaka, Y. Toiyama, T. Yokoe, Y. Okugawa, Y. Ioue, C. Miki, and M. Kusunoki Correlation of CD133. OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy Ann Surg Oncol 16 2009 3488 3498
38. Y.K. Wang, Y. Zhu, F. Qiu, T. Zhang, Z. Chen, S. Zheng, and J. Huang Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells Carcinogenesis 31 2010 1376 1380
39. T. Gaiser, J. Camps, S. Meinhardt, D. Wangsa, Q. Tri Nguyen, S. Varma, C. Dittfeld, L.A. Kunz-Schughart, R. Kemmerling, and M.R. Becker Genome and transcriptome profiles of CD133-positive colorectal cancer cells Am J Pathol 178 2011 1478
40. K.N. Shim, S.A. Jung, Y.H. Joo, and K. Yoo Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer J Gastroenterol 42 2007 120 128
41. P. Bonomi Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung Semin Oncol 29 2002 78 86
42. K. Nabeshima, T. Inoue, Y. Shimao, and T. Sameshima Matrix metalloproteinases in tumor invasion: role for cell migration Pathol Int 52 2002 255 264
43. G.I. Murray, M.E. Duncan, P. O'Neil, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat Med 2 1996 461 462
44. S. Curran, S.R. Dundas, J. Buxton, M.F. Leeman, R. Ramsay, and G.I. Murray Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin Cancer Res 10 2004 8229 8234
45. M.S. Lyall, S.R. Dundas, S. Curran, and G.I. Murray Profiling markers of prognosis in colorectal cancer Clin Cancer Res 12 2006 1184 1191
46. C. Coghlin, and G.I. Murray Current and emerging concepts in tumour metastasis J Pathol 222 2010 1 15
47. K. Shofuda, K. Moriyama, A. Nishihashi, S. Higashi, H. Mizushima, H. Yasumitsu, K. Miki, H. Sato, M. Seiki, and K. Miyazaki Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells J Biochem 124 1998 462 470
48. Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, and H. Nagase Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface J Biol Chem 273 1998 24360 24367
49. W. Ding, M. Mouzaki, H. You, J.C. Laird, J. Mato, S.C. Lu, and C.B. Rountree CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-β-induced apoptosis Hepatology 49 2009 1277 1286